Literature DB >> 12671841

Mechanisms of malnutrition in uremia.

Gianfranco Guarnieri1, Raffaella Antonione, Gianni Biolo.   

Abstract

Loss of lean body mass is common in chronic renal failure and may adversely affect morbidity and mortality of patients. The pathogenesis of protein wasting in chronic renal failure is multifactorial and is reviewed by the authors. When protein kinetics are determined in patients with uncomplicated uremic on conservative treatment by isotopically labeled amino acids, the results indicate that the rates of both protein synthesis and degradation are decreased both at whole body and skeletal muscle levels. On the other hand, if a complication is superimposed (ie, acidosis or infection), protein turnover accelerates, primarily because of proteolysis increase. Therapeutical implications are analyzed in this article. Recently, a cytokine-induced chronic inflammatory response has been proposed to explain the progressive protein loss often observed in these patients even in the absence of complications. Cytokine concentrations often have been found to be increased in both dialyzed and undialyzed chronically uremic patients. Tumor necrosis factor (TNF)-alpha clearance is reduced in uremia because this cytokine is catabolized and excreted mainly by the kidneys. In addition, we found that gene expression for TNF-alpha in circulating blood cells is enhanced in chronically uremic patients, suggesting that an activation of the systemic inflammatory response may contribute to the metabolic, vascular, and immune complications of this disease. Copyright 2003 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671841     DOI: 10.1053/jren.2003.50020

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  6 in total

Review 1.  Alterations of leptin and ghrelin serum concentrations in renal disease: simple epiphenomena?

Authors:  Jörg Dötsch; Kai Nüsken; Michael Schroth; Wolfgang Rascher; Udo Meissner
Journal:  Pediatr Nephrol       Date:  2005-04-05       Impact factor: 3.714

2.  Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study.

Authors:  Garland A Campbell; James T Patrie; Bruce D Gaylinn; Michael O Thorner; Warren K Bolton
Journal:  Nephrol Dial Transplant       Date:  2018-03-01       Impact factor: 5.992

3.  Unplanned hemodialysis initiation and low geriatric nutritional risk index scores are associated with end-stage renal disease outcomes.

Authors:  Ryoichi Maenosono; Tatsuo Fukushima; Daisuke Kobayashi; Tomohisa Matsunaga; Yusuke Yano; Shunri Taniguchi; Yuya Fujiwara; Kazumasa Komura; Hirofumi Uehara; Maki Kagitani; Hajime Hirano; Teruo Inamoto; Hayahito Nomi; Haruhito Azuma
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

4.  Hyperinsulinemia in pediatric patients with chronic kidney disease: the role of tumor necrosis factor-alpha.

Authors:  Hsiao L Lai; Janis Kartal; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2007-06-01       Impact factor: 3.714

5.  Role of leptin and melanocortin signaling in uremia-associated cachexia.

Authors:  Wai Cheung; Pin X Yu; Brian M Little; Roger D Cone; Daniel L Marks; Robert H Mak
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

6.  Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients.

Authors:  Cai Mei Zheng; Chia Chao Wu; Chien Lin Lu; Yi Chou Hou; Mai Szu Wu; Yung Ho Hsu; Remy Chen; Tian Jong Chang; Jia Fwu Shyu; Yuh Feng Lin; Kuo Cheng Lu
Journal:  Int J Med Sci       Date:  2019-10-21       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.